Medication info

Alpiron Tablet (Losartan Potassium)

Prescription medicationApproval withdrawn
Ingredient · strength
Losartan Potassium›Strength being verified
Manufacturer / importer
AlpiBio Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201406177 · Approved 2014.12.31

This product's status changed to Approval withdrawn on 2023.03.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
Who uses it
Adults · Children
Adult dosage
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is inadequate, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. No initial dose adjustment is necessary for elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily, depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).
Children's dosage
Children and adolescents aged 6 years and older who weigh at least 20 kg but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily. Depending on the patient's blood pressure response, the dose may be increased to a maximum of 50mg once daily. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily. Depending on the patient's blood pressure response, the dose may be increased to a maximum of 100 mg once daily. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
AlpiBio Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension

  • Hypertension
  • nephropathy in patients with type 2 diabetes mellitus
View approved original text

This medicine is used for the treatment of hypertension. In particular, it is also helpful in preventing and treating nephropathy in patients with type 2 diabetes mellitus. Therefore, it is effective in improving both blood pressure control and kidney health.

Dosage and Administration

Adult dosage

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is inadequate, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. No initial dose adjustment is necessary for elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily, depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).

Children's dosage

Children and adolescents aged 6 years and older who weigh at least 20 kg but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily. Depending on the patient's blood pressure response, the dose may be increased to a maximum of 50mg once daily. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily. Depending on the patient's blood pressure response, the dose may be increased to a maximum of 100 mg once daily. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. It should not be administered to patients with specific diseases, such as those with an allergy to this medication or with severely impaired liver function, or those with a history of angioedema. Caution must be exercised when administering this drug to elderly patients or those with impaired kidney function, and to patients with hyperkalemia, as care should be taken to avoid excessively low blood pressure. Dizziness or symptoms of hypotension may occur during treatment, so caution is required when driving or operating machinery. During the course of treatment, blood pressure, kidney function, and serum potassium levels should be monitored regularly to ensure they are within normal limits. Interactions may occur when taken with other antihypertensives, potassium supplements, certain diuretics, etc., thus consultation with a physician or pharmacist is mandatory. Adverse reactions such as angioedema, liver dysfunction, muscle pain, skin rash, etc. may occur occasionally and if any unusual symptoms appear, immediate medical attention should be sought. In cases of overdose, symptoms such as hypotension and bradycardia may occur, and immediate emergency treatment is required. This medication is not removed by hemodialysis, so caution is necessary. This drug should not be given to children, especially those under 6 years of age, and it is advisable for breastfeeding women to avoid taking it. Store this medication in a place out of the reach of children, and do not transfer it to another container.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • back pain
  • leg pain
  • dizziness
  • congestion
Show 136 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • angioedema
  • palm desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree AV block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decline
  • decreased libido
  • memory impairment
  • migraine
  • neuralgia
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnolence
  • tremors
  • respiratory distress
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • skin dryness
  • petechial hemorrhage
  • erythema
  • flushing
  • photosensitivity reactions
  • pruritus
  • rash
  • sweating
  • hives
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste abnormality
  • tinnitus
  • vision deterioration
  • erectile dysfunction
  • nocturia
  • polyuria
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylaxis-like syndrome
  • abnormal liver function
  • hepatitis
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste abnormality
  • dry cough
  • erythematous skin condition
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased creatinine
  • increased BUN
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic contractions
  • atrial fibrillation
  • hypoglycemia
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; therefore, it must be stored in a tightly closed container. Additionally, it should be kept in a cool and dry place between 15 and 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.